The veterinary vaccines market in France, excluding foot and mouth vaccines, saw a stable forecast per capita value growth from 2024 to 2028. The per capita value is forecasted to be $15.00 in 2024, growing incrementally to $15.24 by 2028. This represents an approximate annual increase of 0.32% from 2024 to 2028, compared to the $14.90 value recorded in 2023.
The year-on-year growth is modest, indicating a stable demand for veterinary vaccines, but with a low rate of increase, reflective of a mature market. From a 5-year CAGR perspective, the market displays minimal average annual growth.
Trends to watch for include technological advancements in vaccine development, increased emphasis on preventative animal healthcare, and regulatory changes that may impact distribution and demand. Additionally, monitoring shifts in agricultural practices and livestock production could reveal future market opportunities.
